Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 5Liver Neoplasms 1Liver Diseases 1Liver Abscess 1Carcinoma 1Adenoma 1

Interventions

Hepatectomy 10Blood Specimen Collection 9Sorafenib 7Polymerase Chain Reaction 4Biopsy 4regorafenib 3Mass Spectrometry 3Liver Transplantation 3Immunohistochemistry 3Chemoembolization, Therapeutic 3Walking Speed 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Magnetic Resonance Imaging 2Gene Expression Profiling 2Bevacizumab 2trastuzumab deruxtecan 1taxane 1spartalizumab 1sintilimab 1lenvatinib 1gadolinium ethoxybenzyl DTPA 1donafenib 1carmofur 1camrelizumab 1cabozantinib 1atezolizumab 1apatinib 1anlotinib 1Yttrium-90 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Liver Neoplasms × gadolinium ethoxybenzyl DTPA × Clear all
NCT01043523 2016-11-28

Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

Bayer

Completed
52 enrolled 27 charts
Gastrointestinal

Adenoma, Carcinoma, Carcinoma, Hepatocellular, Liver Abscess, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡